Krystal Biotech Announces First Quarter 2023 Financial : vim

PDUFA date of May 19, 2023Presented clinical data at ARVO on topical application of B-VEC to the eye to treat ocular complications in a patient with...

Related Keywords

Pennsylvania , United States , Japan , Australia , Krishs Krishnan , , Exchange Commission , European Medicines Agency , Nasdaq , Association For Research , Krystal Biotech Inc , Company Biologics License Application , Us Food Drug Administration , Ministry Of Health , Compassionate Use Program , Jeune Aesthetics Inc , Compassionate Use , Dystrophic Epidermolysis Bullosa , Drug Administration , Prescription Drug User Fee Act , Biologics License Application , Pediatric Investigation Plan , Marketing Authorization Application , Cartagena Act , Therapeutics Development Network , Cystic Fibrosis Foundation , Jeune Aesthetics , Krystal Biotech , Private Securities Litigation Reform Act , Balance Sheet Data , Nasdaq Krys , Nc ,